Viewing Study NCT00104767


Ignite Creation Date: 2025-12-25 @ 12:33 AM
Ignite Modification Date: 2026-02-18 @ 3:40 AM
Study NCT ID: NCT00104767
Status: COMPLETED
Last Update Posted: 2015-10-02
First Post: 2005-03-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Sponsor: Jonsson Comprehensive Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage IIIB non-small cell lung cancer View
None stage IV non-small cell lung cancer View
None recurrent non-small cell lung cancer View